Home-based transcranial direct current stimulation for persistent pain state in rheumatoid arthritis: a randomized trial
Pilotti et al., 2026. Advances in Rheumatology
This randomized controlled trial tested whether home-based tDCS reduces persistent pain in rheumatoid arthritis when inflammation is already well controlled.
- Design: A double-blind trial with 34 women with rheumatoid arthritis, randomized to active or sham tDCS.
- Treatment: 20 home sessions over 4 weeks at 2 mA for 20 minutes, with the anode over the left motor cortex (M1). Sessions were remotely supervised.
- Main result: Pain dropped more with active tDCS than with sham (−33.5 mm vs −14.1 mm on a 100 mm scale). Physical function also improved more, and painkiller use fell by 62%.
- Adherence & safety: Participants completed 91% of planned sessions. Side effects were mild to moderate and no more common than with sham.
CONCLUSION: Home-based tDCS reduced pain, disability and painkiller use in rheumatoid arthritis patients whose pain persists despite controlled inflammation.